Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling

[1]  H. Yin,et al.  Small-Molecule Modulators of Toll-like Receptors. , 2020, Accounts of chemical research.

[2]  Tao Yan,et al.  Selective targeting of the TLR4 co-receptor, MD2, prevents colon cancer growth and lung metastasis , 2020, International journal of biological sciences.

[3]  Yibo Wang,et al.  Exploring Methamphetamine Nonenantioselectively Targeting Toll-like Receptor 4/Myeloid Differentiation Protein 2 by in Silico Simulations and Wet-Lab Techniques , 2020, J. Chem. Inf. Model..

[4]  N. Woodling,et al.  Shifting equilibriums in Alzheimer’s disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis , 2020, Neural regeneration research.

[5]  M. Atzori,et al.  Nicotine smoking concentrations modulate GABAergic synaptic transmission in murine medial prefrontal cortex by activation of α7* and β2* nicotinic receptors , 2020, The European journal of neuroscience.

[6]  L. Watkins,et al.  Lovastatin inhibits Toll-like receptor 4 signaling in microglia by targeting its co-receptor myeloid differentiation protein 2 and attenuates neuropathic pain , 2019, Brain, Behavior, and Immunity.

[7]  S. Maier,et al.  Methamphetamine activates Toll-like receptor 4 to induce central immune signaling within the ventral tegmental area and contributes to extracellular dopamine increase in the nucleus accumbens shell. , 2019, ACS chemical neuroscience.

[8]  L. Watkins,et al.  Stereochemistry and innate immune recognition: (+)‐norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll‐like receptor 4 signaling , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Sanhita Maity,et al.  NMR Methods to Characterize Protein-Ligand Interactions , 2019, Natural Product Communications.

[10]  M. Montopoli,et al.  Flavonoids Regulate Lipid Droplets Biogenesis in Drosophila melanogaster , 2019, Natural Product Communications.

[11]  D. Hatsukami.  Reducing Nicotine in Cigarettes to Minimally Addictive Levels: A New Frontier for Tobacco Control. , 2018, JAMA psychiatry.

[12]  Yibo Wang,et al.  Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists , 2018, J. Chem. Inf. Model..

[13]  N. Morioka,et al.  Regulation by Nicotinic Acetylcholine Receptors of Microglial Glutamate Transporters: Role of Microglia in Neuroprotection , 2018 .

[14]  J. A. Fernández,et al.  Structural Studies of Nicotinoids: Cotinine versus Nicotine. , 2017, Chemistry.

[15]  Yili Yang,et al.  Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3 , 2017, Journal of Molecular Medicine.

[16]  Wang Xiaohui,et al.  Toll-like Receptor 4 Small Molecule Modulators , 2016 .

[17]  M. L. Hughes,et al.  Differential Effects of Hydrophobic Core Packing Residues for Thermodynamic and Mechanical Stability of a Hyperthermophilic Protein. , 2016, Langmuir : the ACS journal of surfaces and colloids.

[18]  Y. Zhang,et al.  Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4 , 2015, British journal of pharmacology.

[19]  L. Watkins,et al.  Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists. , 2015, Journal of medicinal chemistry.

[20]  S. Maier,et al.  DAT isn’t all that: cocaine reward and reinforcement requires Toll Like Receptor 4 signaling , 2014, Molecular Psychiatry.

[21]  M. Kulshrestha,et al.  A nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia. , 2014, Fitoterapia.

[22]  P. Nordlund,et al.  The cellular thermal shift assay for evaluating drug target interactions in cells , 2014, Nature Protocols.

[23]  Yili Yang,et al.  MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines , 2013, Cell Research.

[24]  Jacob Thomas,et al.  Morphine activates neuroinflammation in a manner parallel to endotoxin , 2012, Proceedings of the National Academy of Sciences.

[25]  S. Han,et al.  Myeloid differentiation 2 as a therapeutic target of inflammatory disorders. , 2012, Pharmacology & therapeutics.

[26]  J. Angulo,et al.  STD-NMR: application to transient interactions between biomolecules—a quantitative approach , 2011, European Biophysics Journal.

[27]  Franklin L. Nobrega,et al.  Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein Binding , 2011 .

[28]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[29]  H. Schuller.  Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? , 2009, Nature Reviews Cancer.

[30]  Marcel Leist,et al.  The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. , 2009, ALTEX.

[31]  Jianxun Xie,et al.  TC‐5214 (S‐(+)‐Mecamylamine): A Neuronal Nicotinic Receptor Modulator with Antidepressant Activity , 2008, CNS neuroscience & therapeutics.

[32]  P. Pristovsek,et al.  Taxanes inhibit human TLR4 signaling by binding to MD‐2 , 2008, FEBS letters.

[33]  P. Pristovsek,et al.  MD‐2 as the target of curcumin in the inhibition of response to LPS , 2007, Journal of leukocyte biology.

[34]  Gwang Lee,et al.  Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action , 2007, The European journal of neuroscience.

[35]  A. C. Collins,et al.  Guidelines on nicotine dose selection for in vivo research , 2007, Psychopharmacology.

[36]  J. Buccafusco,et al.  The potential role of cotinine in the cognitive and neuroprotective actions of nicotine. , 2003, Life sciences.

[37]  G. Baziard-Mouysset,et al.  Evidence that nicotine acetylcholine receptors are not the main targets of cotinine toxicity. , 1999, Toxicology letters.

[38]  L. Dwoskin,et al.  Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. , 1997, Biochemical pharmacology.